TrialRandomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Trial details
- Registry ID
- NCT03519386
- Phase
- Phase 3
Drug research
G2-TR intraocular implant containing travoprost
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity has not yet been verified against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%NCT03519386 | Glaukos Corporation | Phase 3 | Completed | 2022-04-05Actual |
| Clinical Study Comparing Two Models of a Travoprost Intraocular ImplantNCT03868124 | Glaukos Corporation | Phase 3 | Completed | 2022-06-10Actual |
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
Trial details
- Registry ID
- NCT03868124
- Phase
- Phase 3
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |